share_log

Genolier Innovation Hub, an Innovative Global Healthcare Center, Is Inaugurated Today in Switzerland

Genolier Innovation Hub, an Innovative Global Healthcare Center, Is Inaugurated Today in Switzerland

瑞士創新全球醫療中心Genolier Innovation Hub 今天揭幕
PR Newswire ·  09/27 20:30

U.S.-based GE Healthcare and Accuray are among first commercial partners; A platform of excellence in healthcare fosters collaboration across fields and industries bringing solutions to patients faster

總部位於美國的GE Healthcare和Accuray是首批商業合作伙伴之一;卓越的平台在醫療保健領域促進跨領域和跨行業的合作,爲患者提供解決方案的速度更快

GENOLIER, Switzerland, Sept. 27, 2024 /PRNewswire/ -- Seeking to harness the power of interactions between scientists and physicians to bring late stage medical and technological advances to patients faster, the Genolier Innovation Hub was officially inaugurated today. The Hub is the first of its kind in Europe and one of a few worldwide.

瑞士日內瓦,2024年9月27日/PRNewswire/--致力於利用科學家和醫生之間的互動力量,將晚期醫學和技術進步更快地帶給患者,瑞士Genolier創新中心今天正式揭幕。該中心是歐洲首個,也是全球爲數不多的創新中心之一。

The Genolier Innovation Hub aspires to become a leader in developing innovative solutions for global health challenges.

Genolier創新中心立志成爲全球健康挑戰創新解決方案的領導者。

Post this
發佈此貼
Aerial view of Genolier Innovation Hub (photo by Olivier Maire)
Genolier創新中心的航拍視圖(Olivier Maire拍攝)

Located in Genolier, Switzerland, between Geneva and Lausanne in the heart of the Swiss Health Valley, the opening of the Genolier Innovation Hub marks a cumulative two-and-a-half years of work to create an environment conducive to fostering collaboration and bringing innovative health solutions to patients faster. The Genolier Innovation Hub's opening reflects an initial investment of CHF 100 million ($118 million US dollars) by Infracore SA, a Swiss-based healthcare infrastructure company. By integrating key players from industry, research and public and private hospitals from Switzerland and beyond, the Genolier Innovation Hub aspires to become a global leader in developing innovative solutions for current and future health challenges.

位於瑞士日內瓦和洛桑之間的Genolier,地處瑞士健康谷中心,Genolier創新中心的開幕標誌着連續兩年半的工作,創造一個有利於促進合作並更快爲患者提供創新醫療解決方案的環境。Genolier創新中心的開幕反映了瑞士醫療基礎設施公司Infracore SA投入的10000萬瑞士法郎(合11800萬美元)的初始投資。通過整合來自瑞士及其他國家的行業、研究和公私立醫院的關鍵參與者,Genolier創新中心立志成爲全球在當前和未來健康挑戰領域開發創新解決方案的領導者。

Designed to enable interactions between scientists, physicians, and technicians from medtech, pharma, biotech, bioscience and digital health fields, the Genolier Innovation Hub offers a multitude of different workspaces equipped with the latest technologies to support new discoveries and advances. The Hub includes 25,000 square meters of offices and laboratories, meeting rooms, and an auditorium that can seat 300 people. These initiatives are essential to the Hub's mission to disseminate knowledge and train tomorrow's professionals. The Hub launches with four commercial partners, including two U.S.-based companies – GE Healthcare and Accuray – as well as Biopôle and RaySearch Laboratories.

旨在促進醫學科技、製藥、生物技術、生物科學和互聯網醫療領域的科學家、醫生和技術人員之間的互動設計,Genolier創新中心提供配備最新技術的多樣化工作空間,支持新發現和進步。該中心包括25000平方米的辦公室和實驗室、會議室以及可容納300人的禮堂。這些舉措對該中心傳播知識並培訓明日專業人員的使命至關重要。中心的啓動有四家商業合作伙伴,包括兩家總部位於美國的公司—GE Healthcare和Accuray—以及Biopôle和RaySearch Laboratories。

Accuray, which specializes in high-precision radiotherapy, has set up its state-of-the-art equipment and has opened its global center of excellence there for training its customers. GE Healthcare is using the Hub as a global training center for doctors and technicians – a critical part of the company's global training strategy. It is also collaborating with Genolier Innovation Hub on R&D for oncology projects.

精確射線專注於高精度放療,已在那裏建立了最先進的設備,並開設了全球卓越中心,爲培訓客戶。 GE Healthcare正在將該中心用作全球醫生和技術人員的培訓中心,這是公司全球培訓戰略的關鍵組成部分。同時還與Genolier創新中心合作進行腫瘤項目的研發。

Anna Gräbner, CEO of the Genolier Innovation Hub, stated: "The Genolier Innovation Hub goes far beyond the scope of a traditional research center. It is an environment where ideas come to life, and barriers between research, industry, and clinical practice are eliminated. We aim to create an ecosystem where innovation thrives seamlessly and in an interdisciplinary manner, with a focus on real-world clinical application."

Genolier創新中心的首席執行官安娜·格蕾布納表示:「Genolier創新中心遠遠超出了傳統研究中心的範圍。這是一個讓想法變爲現實,消除了研究、工業和臨床實踐之間障礙的環境。我們旨在創建一個創新蓬勃發展、跨學科的生態系統,重點關注現實臨床應用。」

Antoine Hubert, Delegate of the Board of AEVIS VICTORIA, the holding company that invested in this project, added: "To truly redefine medical approach, significant investments and close collaboration among all health stakeholders are essential. Our Hub represents this shared vision, where technology and clinical practice converge to improve patients' quality of life."

AEVIS VICTORIA董事會代表安託萬·于貝爾特,這家投資了該項目的控股公司,補充說:「要真正重新定義醫療方法,需要進行重大投資,各醫療利益相關者之間的緊密協作至關重要。我們的中心代表了這一共同願景,科技和臨床實踐融合,以改善患者生活質量。」

Global Impact

全球影響

This center is not only an asset for the region but also for healthcare on a global scale. By integrating key players from industry, research, public and private hospitals from Switzerland and beyond, the Genolier Innovation Hub aspires to become a global leader in developing innovative solutions for current and future health challenges.

這個中心不僅是該地區的資產,也是全球醫療保健的資產。通過整合來自瑞士及全球各地工業、研究、公共和私人醫院的關鍵參與者,Genolier創新中心立志成爲發展當前和未來健康挑戰創新解決方案的全球領導者。

Oscar Matzinger, Medical Director of Radio-Oncology at Swiss Medical Network, one of the site's partners, stated: "The Hub enables unprecedented interaction between researchers and clinicians, facilitating the development and rapid adoption of new, tailored medical technologies that meet practitioners' needs."

瑞士醫療網絡Radio-Oncology的醫學主任奧斯卡·馬青格表示:「中心實現了研究人員和臨床醫生之間前所未有的互動,促進了新型定製醫療技術的開發和快速應用,以滿足從業人員的需求。」

The inauguration of the Genolier Innovation Hub marks the beginning of a new era for health innovation in Switzerland and internationally. The collaborations and innovations emerging from this center of excellence are anticipated to contribute to the continuous improvement of health care for patients and future generations.

Genolier創新中心的開幕標誌着瑞士和國際醫療創新的新紀元的開始。從這個卓越中心湧現出的合作和創新預計將有助於持續改進患者和未來一代的醫療保健。

About Genolier Innovation Hub SA

關於Genolier Innovation Hub SA

Genolier Innovation Hub, located just 20 minutes from Geneva airport in the heart of the Swiss Health Valley, offers over 25,000 m2 dedicated to medical innovation, where physicians, caregivers, researchers, scaleups, companies, specialized industries, hospitals, clinics and academic institutions meet and collaborate to accelerate progress and innovation in health care. Its mission, from laboratory to clinical application, is to ease the transition "from bench to bedside" by promoting translational research, the development of new solutions and educational opportunities, for the benefit of patients. With a focus on medtech, pharmaceuticals, digital technologies and biosciences, the Genolier Innovation Hub is a dynamic meeting place for international health care players. Its state-of-the-art 300-seat auditorium, featuring a 180-degree immersive screen, is a location for high-level conferences and keynote presentations.

Genolier Innovation Hub位於瑞士健康之谷中心,距離日內瓦機場僅20分鐘車程,佔地面積超過25,000平方米,專注於醫療創新,醫生、護理人員、研究人員、規模擴大公司、專業行業、醫院、診所和學術機構齊聚一堂,共同推動衛生保健領域的進步與創新。其使命是從實驗室到臨床應用,通過推廣轉化研究、開發新解決方案和教育機會,爲患者謀利。Genolier Innovation Hub以醫療技術、製藥、數字技術和生物科學爲重點,是國際衛生保健領域的動態交匯點。其擁有300座位的最先進演講廳,設有180度沉浸式屏幕,是舉辦高水平會議和主題演講的場所。

Facts & Figures

事實與數字

Stakeholders:

利益相關者:

  • Project owner: Infracore SA
  • Architect: Gabriele Rossi, Archilab SA
  • Interior design: Kristian Gavoille, Paris
  • General contractor: ROOF SA
  • 項目業主:Infracore SA
  • 建築師:Gabriele Rossi,Archilab SA
  • 室內設計:Kristian Gavoille,巴黎
  • 總承包商:ROOF SA

Technical data

技術數據

  • Gross floor area: 25,000 m2
  • Usable area: 11,272 m2
  • Layout: 3 floors for offices, laboratories, 2 surgery spaces, radiotherapy bunkers, technical rooms, an auditorium (300-seat amphitheater), diverse conference rooms, parking floor and a green roof
  • Construction permit granted in December 2020
  • La Joy partial assignment plan signed with the Genolier commune in 2017
  • 總建築面積: 25,000平方米
  • 可使用面積: 11,272平方米
  • 佈局: 3層辦公室、實驗室,2個手術間,放射治療掩體,技術室,一個擁有300個座位的禮堂,各類會議室,停車樓層和綠色屋頂
  • 建設許可證於2020年12月頒發
  • 2017年與Genolier社區簽署了La Joy部分分配計劃

3D architectural structure

3D建築結構

  • Spaces for companies + offices + laboratories (fully modular zone): 7,000 m2
  • Event spaces for conferences, meetings, workshops and seminars: 1,000 m2
  • Technical facility with bunkers for radiology and radiotherapy + surgical rooms + classrooms: 2,000 m2
  • Rooftop garden: 6,000 m2
  • 公司+辦公室+實驗室空間(全模塊化區域): 7,000平方米
  • 會議、會議、研討會和研討會的活動空間:1,000平方米
  • 具有放射學和放射治療+手術室+教室的技術設施:2,000平方米
  • 屋頂花園:6,000平方米

Financial data

財務數據

  • Investor: AEVIS VICTORIA SA
  • Total project costs: CHF 100 million (65 million for the construction)
  • 投資者:AEVIS VICTORIA SA
  • 項目總成本:1億瑞士法郎(施工費6500萬)

Timeframe

時間範圍

  • Start of construction: June 2021
  • Foundation stone laid: November 15, 2021
  • Completion of structural work: end of 2023
  • Completion of interiors: Q2, 2024
  • Building delivery: June 30, 2024
  • Opening date: Friday, September 27, 2024
  • 施工開始時間:2021年6月
  • 落成基石日期:2021年11月15日
  • 結構工程完成:2023年底
  • 室內裝修完成:2024年第二季度
  • 建築交付日期:2024年6月30日
  • 開放日期:2024年9月27日星期五

Location

地點

  • Genolier (Switzerland, Canton of Vaud), 25 min from Geneva, 1.5 hrs. from Bern, 2.5 hrs. from Zurich
  • Genolier(瑞士瓦州州府競比基拉地區),距離日內瓦25分鐘、伯爾尼1.5小時、蘇黎世2.5小時

SOURCE Genolier Innovation Hub

源自 Genolier 創新中心

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力
9k+
9k+

Digital Media
數字媒體

Outlets
賣場
270k+
270k+

Journalists
新聞記者

Opted In
已選擇加入
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論